TSX:EDT - Post Discussion
Post by
TechOne on Nov 22, 2024 3:33pm
Spectral on Linkedin Today
PMX (Polymyxin B Hemoperfusion) Commercialization & Baxter Partnership Activities: In anticipation of a positive Tigris trial outcome, the Company has been working closely with Baxter on post-approval marketing plans for PMX commercialization. This includes developing product branding, pricing, and roll-out plans with numerous Baxter departments, including marketing, regulatory, clinical and reimbursement. Baxter has communicated its intention to undertake a broad marketing campaign on day one of FDA approval for PMX. Read more https://lnkd.in/d4jAAS8J
Be the first to comment on this post